Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders
Year: 2021
Type: article
Study design: Observational Study
Authors: Lusi Zhang, Scot Kristian Hill, Bin Guo, Baolin Wu, Ney Alliey-Rodriguez, Seenae Eum, Paulo Lizano, Elena I. Ivleva, James L. Reilly, Richard S.E. Keefe, Sarah K. Keedy, Carol A. Tamminga, Godfrey D. Pearlson, Brett A. Clementz, Matcheri S. Keshavan, Elliot S. Gershon, John A. Sweeney, Jeffrey R. Bishop
Institutions: University of Minnesota, Rosalind Franklin University of Medicine and Science, University of Chicago, Shenandoah University, Beth Israel Deaconess Medical Center, Harvard University, The University of Texas Southwestern Medical Center, Northwestern University, Duke University, Duke Medical Center, Yale University, University of Georgia, University of Cincinnati
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1044130170, Schizophrenia Pharmacogenetics: cognition and symptom response to antipsychotics, 5/5 BIPOLAR-SCHIZOPHRENIA NETWORK FOR INTERMEDIATE PHENOTYPES (B-SNIP) - Resubmission - 1, 2/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (B-SNIP2), G208937423, G2241124166, G2273952854, 1/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (B-SNIP 2) - Resu, G2458313802, Antipsychotic Treatment Effects on Attention & Working Memory in Schizophrenia, G4136061041, G4572150161, G4863277230, G4991243177, G5246119025, G561811038, G568434048, G5926081180, G6528626969, G661573911, 3/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (BSNIP-2), Yale Clinical and Translational Science Award
OpenAlex ID: W3211145128